InsiderClue

Every filing, one decision per row.

Transactions

One row for every decision an insider filed. Open-market buying and selling only. Vesting, grants and the shares withheld to pay the tax on them are not decisions.

Views

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

Create an account Sign in
Companies 1/25
ORKA
Result 25 decisions over 120 months
Reset filters
Direction ?
Both25 Bought14 Sold11
Sort by ?
Most recent Largest amount Share of holding
Window ?
1 mo 12 mo 120 mo
Plan ?
Any Discretionary Scheduled (10b5-1) Not stated
Minimum amount ?
Any $100K $1M $10M $100M $500M
Share of their own holding ?
What the chief executive holds ?
Company: ORKA Plan: Discretionary
Company
Date
Insider
Role
Action ?
Shares
Amount
Of holding
ORKA Oruka Therapeutics, Inc.
15 Sep 2026
Klein Lawrence Otto
Chief Executive Officer
Sold at will
2,452
$234.68K
0.3%
ORKA Oruka Therapeutics, Inc.
15 Sep 2026
Quinlan Paul T
General Counsel
Sold at will
1,039
$99.44K
3.3%
ORKA Oruka Therapeutics, Inc.
15 Sep 2026
Sandler Laura Lee
Chief Operating Officer
Sold at will
906
$86.71K
0.4%
ORKA Oruka Therapeutics, Inc.
1 Jul 2026
Fairmount Funds Management LLC
Director indirect
Sold at will
3,553,410
$300.01M
75.8%
ORKA Oruka Therapeutics, Inc.
15 Jun 2026
Klein Lawrence Otto
Chief Executive Officer
Sold at will
1,729
$120.49K
0.2%
ORKA Oruka Therapeutics, Inc.
15 Jun 2026
Quinlan Paul T
General Counsel
Sold at will
733
$51.08K
2.3%
ORKA Oruka Therapeutics, Inc.
15 Jun 2026
Sandler Laura Lee
Chief Operating Officer
Sold at will
600
$41.81K
0.3%
ORKA Oruka Therapeutics, Inc.
16 Mar 2026
Klein Lawrence Otto
Chief Executive Officer
Sold at will
1,729
$71.41K
0.2%
ORKA Oruka Therapeutics, Inc.
16 Mar 2026
Quinlan Paul T
General Counsel
Sold at will
733
$30.27K
2.3%
ORKA Oruka Therapeutics, Inc.
16 Mar 2026
Sandler Laura Lee
Chief Operating Officer
Sold at will
600
$24.78K
0.3%
ORKA Oruka Therapeutics, Inc.
16 Mar 2026
Agarwal Arjun
Senior Vice President, Finance
Sold at will
395
$16.31K
2.1%
ORKA Oruka Therapeutics, Inc.
14 Feb 2025
Venrock Healthcare Capital Partners III, L.P.
10% owner indirect
Bought
88,794
$1.02M
2.2%
ORKA Oruka Therapeutics, Inc.
13 Feb 2025
Venrock Healthcare Capital Partners III, L.P.
10% owner indirect
Bought
14,950
$173.87K
0.4%
ORKA Oruka Therapeutics, Inc.
12 Feb 2025
Venrock Healthcare Capital Partners III, L.P.
10% owner indirect
Bought
8,971
$106.40K
0.2%
ORKA Oruka Therapeutics, Inc.
11 Feb 2025
Venrock Healthcare Capital Partners III, L.P.
10% owner indirect
Bought
9,593
$105.04K
0.2%
ORKA Oruka Therapeutics, Inc.
10 Feb 2025
Venrock Healthcare Capital Partners III, L.P.
10% owner indirect
Bought
574
$6.26K
0.0%
ORKA Oruka Therapeutics, Inc.
16 Aug 2024
JANUS HENDERSON GROUP PLC
10% owner indirect
Bought 2×
5,818
$17.07K
0.3%
ORKA Oruka Therapeutics, Inc.
25 Jul 2024
JANUS HENDERSON GROUP PLC
10% owner indirect
Bought
30,227
$92.29K
1.5%
ORKA Oruka Therapeutics, Inc.
24 Jul 2024
JANUS HENDERSON GROUP PLC
10% owner indirect
Bought 3×
189,856
$606.87K
10.0%
ORKA Oruka Therapeutics, Inc.
11 Jul 2024
JANUS HENDERSON GROUP PLC
10% owner indirect
Bought
94,537
$326.30K
5.3%
ORKA Oruka Therapeutics, Inc.
10 Jul 2024
JANUS HENDERSON GROUP PLC
10% owner indirect
Bought 2×
55,463
$192.13K
3.2%
ORKA Oruka Therapeutics, Inc.
9 Jul 2024
JANUS HENDERSON GROUP PLC
10% owner indirect
Bought
16,917
$58.09K
1.0%
ORKA Oruka Therapeutics, Inc.
8 Jul 2024
JANUS HENDERSON GROUP PLC
10% owner indirect
Bought 2×
47,492
$164.19K
2.8%
ORKA Oruka Therapeutics, Inc.
5 Jul 2024
JANUS HENDERSON GROUP PLC
10% owner indirect
Bought 2×
28,326
$97.07K
1.7%
ORKA Oruka Therapeutics, Inc.
3 Jul 2024
JANUS HENDERSON GROUP PLC
10% owner indirect
Bought
166,042
$589.57K
11.2%
Showing 1–25 of 25.